Alternate day caplacizumab for immune thrombotic thrombocytopenic purpura

Verifisert
National Institute for Health and Care Research
Type
Tilskudd
Frist
Utløpt 6. mai 2026
Program
Health Technology Assessment

Om ordningen

- Funding programme: Health Technology Assessment - Opening date: 2025-08-28 - Closing date: 2026-05-06

We're looking to fund a single study to investigate whether treatment should be given on alternate days rather than everyday for the rare blood disorder; immune thrombotic thrombocytopenic purpura (TTP).

Full eligibility, award value and application detail are published on the opportunity's own page: https://www.nihr.ac.uk/funding/alternate-day-caplacizumab-immune-thrombotic-thrombocytopenic-purpura/2025376

Ofte stilte spørsmål

Hvem står bak Alternate day caplacizumab for immune thrombotic thrombocytopenic purpura?
Alternate day caplacizumab for immune thrombotic thrombocytopenic purpura er en tilskudd fra National Institute for Health and Care Research.
Hvordan søker man på Alternate day caplacizumab for immune thrombotic thrombocytopenic purpura?
Du søker hos National Institute for Health and Care Research via lenken på denne siden. Virkely hjelper deg å skrive selve søknaden — fra organisasjonsnummer til ferdig tekst.

Skal du søke Alternate day caplacizumab for immune thrombotic thrombocytopenic purpura?

Virkely hjelper deg å skrive søknaden — fra organisasjonsnummer til ferdig tekst. Ingen innlogging.

Start søknaden

Flere ordninger fra National Institute for Health and Care Research

Relaterte kategorier